View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorised
April 8, 2020

Council of Europe calls for vigilance against counterfeit Covid-19 medicines

By Allie Nawrat

The continent Europe’s human rights organisation the Council of Europe has called on its 47 member states to be extra vigilant against counterfeit medicines during the Covid-19 pandemic.

Its MEDICRIME Convention committee notes that there is likely to be an increase in falsified medicines as criminals take advantage of the pandemic and its disruption to healthcare systems and supply chains. Counterfeit medicines are at best ineffective, and at worst dangerous, and sometimes life-threatening, to patients who take them.

Therefore, the committee recommends that countries should better monitor online platforms selling medicines to healthcare systems to ensure they have not been infiltrated by criminals. It also calls for cross agency and international cooperation to break falsified medicines supply chains and support legitimate suppliers.

Related Companies

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy